Adverum Biotechnologies Inc reports results for the quarter ended in December - Earnings Summary

Adverum Biotechnologies

29/03/2022 22:47

* Adverum Biotechnologies Inc  ADVM.OQ  reported a quarterly
adjusted loss of 35 cents​​ per share for the quarter ended in
December. The mean expectation of three analysts for the quarter
was for a loss of 34 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Adverum Biotechnologies Inc's reported EPS for the quarter
was a
loss of 35 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Adverum Biotechnologies Inc shares had fallen by 21.6%
this
quarter.
    * The company reported a quarterly loss of $34.41 million.
    * Wall Street's median 12-month price target for Adverum
Biotechnologies Inc is $4.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 29 at 09:47 p.m.  ​All
figures in US dollars unless otherwise stated